Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,83 USD | +3,51% | -4,25% | -7,49% |
Omzet 2024 * | - | Omzet 2025 * | 3 mln. 2,81 mln. | Marktkapitalisatie | 116 mln. 108 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -112 mln. -105 mln. | Nettowinst (verlies) 2025 * | -120 mln. -112 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 203 mln. 189 mln. | Nettoliquiditeiten 2025 * | 124 mln. 116 mln. | EV/omzet 2025 * | -2,76 x |
K/w-verhouding 2024 * |
-1,25
x | K/w-verhouding 2025 * |
-1,62
x | Werknemers | 20 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 91,96% |
Recentste transcriptie over Relmada Therapeutics, Inc.
1 dag | +3,51% | ||
1 week | -4,25% | ||
Lopende maand | -17,63% | ||
1 maand | -18,34% | ||
3 maanden | +5,51% | ||
6 maanden | +21,97% | ||
Lopend jaar | -7,49% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paolo Manfredi
FOU | Founder | 62 | 31-05-12 |
Sergio Traversa
CEO | Chief Executive Officer | 63 | - |
Maged Shenouda
DFI | Director of Finance/CFO | 59 | 12-11-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 78 | 14-07-15 | |
Sergio Traversa
CEO | Chief Executive Officer | 63 | - |
Maged Shenouda
DFI | Director of Finance/CFO | 59 | 12-11-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.10% | 0 M€ | 0,00% | - | |
0.03% | 509 M€ | -.--% | ||
0.00% | 237 M€ | +2,89% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 3,83 | +3,51% | 80 013 |
25-04-24 | 3,7 | -4,15% | 85 873 |
24-04-24 | 3,86 | -1,28% | 114 592 |
23-04-24 | 3,91 | +1,03% | 143 632 |
22-04-24 | 3,87 | -3,25% | 178 128 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-7,49% | 112 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,37% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-14,85% | 15,52 mld. | |
+3,21% | 13,86 mld. | |
+33,54% | 12,04 mld. |